Alzheimer's disease (AD), also mentioned as
Alzheimer's, is an enduring neurodegenerative disease that usually starts slowly and worsens over time. The most common early symptom of
Alzheimer's is difficulty memorizing newly learned information because
Alzheimer's changes naturally initiate in the part of the brain that affects learning. As
Alzheimer's
spreads through the brain, it leads to increasingly severe symptoms,
including confusion, mood and behavior changes; deepening misperception
about events, time and place; unfounded suspicions about family, friends
and professional caregivers; more serious
memory loss and behavior changes; and
difficulty speaking, swallowing and walking.
Around the world, no less than 44 million individuals are living with
dementia
this number is believed to get double by 2030 and more than triple by
2050 to 115 million. A significant part of the expansion will be in
creating nations like Western Europe and North America. Officially 62%
of individuals with
dementia live in creating nations. Today, more than 35 million individuals overall, are currently living with this condition.
Alzheimer’s Disease is complex, and it is doubtful that any one drug or other intervention can effectively treat it.
Alzheimer’s
has no current cure, but treatments for symptoms are available and
research continues. In two decades, it is estimated that 1.4 million
Canadians will have
dementia, costing the economy nearly $300 billion every year. All inclusive,
dementia cost $600 billion a year.
The scope of the Conference
Alzheimer’s Congress 2020 provides a great platform by gathering eminent
professors, researchers,
students, and delegates to exchange new ideas. The conference will
cover a wide range of topics and allow participants to discuss the
management of diseases. Best poster presenters will be judged and
awarded during the conference. To encourage broad participation from all
over the
world Conference Series LLC Ltd is offering reduced registration fee for students.
Conference Highlights
-
Alzheimers disease and Dementia
-
Vascular Dementia
-
Dementia with Lewy Bodies
-
Managing Dementia
-
Imaging Techniques
-
Pathophysiology and Disease Mechanism
-
Geriatric and Cognitive Disorder
-
Animal models and Translational Medicine
-
Current Research in Therapeutic Targets
-
Care Practice and Awareness
-
Behavioral Problems in Alzheimers disease
-
Insulin Resistance on the development of Alzheimers disesase
-
Frontotemporal Dementia
-
Neurological Diseases
-
Neurodegenerative Diseases
-
Alzheimers Disease and Type 2 Diabetes
Conference Opportunities For -
Researchers and Faculty Members:
-
Speaker Presentations
-
Poster Display
-
Symposium hosting (4-5 member team)
-
Workshop organizing
For Universities, Associations & Societies:
-
Association Partnering
-
Collaboration proposals
-
Academic Partnering
-
Group Participation
For Students and Research Scholars:
-
Poster Competition (Winner will get Best Poster Award)
-
Young Researcher Forum (YRF Award to the best presenter)
-
Student Attendee
-
Group registrations
For Business Delegates:
-
Speaker Presentations
-
Symposium hosting
-
Networking opportunities
For Product Manufacturers:
-
Exhibitor and Vendor Booths
-
Sponsorships opportunities
-
Marketing and Networking with clients
-
Workshop organizing
Why attend?
Alzheimer’s Congress 2020 will give a chance to all partners chipping away at
Alzheimer's infection and Dementia to discuss their work.
Alzheimer's Congress 2020 will assemble prestigious speakers, important examiners, specialists, neurologists and
Dementia
analysts from both scholarly community and social insurance industry
will consolidate to talk about their perspectives and research. The
gathering will be involved sessions by world-class specialists in the
field of neurology. In
Alzheimer’s Congress 2020,
global symposiums, B2B gatherings, worldwide workshops will likewise be
sorted out to talk about the particular points in the field of
Alzheimer's Disease and Dementia and Neurology.
Conference Highlights
